Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT])
Michael H. Alderman, Barry R. Davis, Linda B. Piller, Charles E. Ford, M. Sarah Baraniuk, Sara L. Pressel, et al. ALLHAT Collaborative Research Group
Amer J Cardiol 2016; 117(1):105–115. DOI:
http://dx.doi.org/10.1016/j.amjcard.2015.10.012